All-cause cancer mortality over 15 years in multi-ethnic Mauritius: The impact of diabetes and intermediate forms of glucose tolerance

International Journal of Cancer

Volumn 131, Issue 10, 2012, Pages 2385-2393

  Harding, Jessica L ^a   Soderberg, Stefan ^a,b   Shaw, Jonathan E ^a   Zimmet, Paul Z ^a   Pauvaday, Vassen ^c   Kowlessur, Sudhir ^c   Tuomilehto, Jaakko ^d,e,f   Alberti, K George M M ^g   Magliano, Dianna J ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UMEÅ UNIVERSITY   (Sweden)

^c Ministry of Health and Quality of Life   (Mauritius)

^d UNIVERSITY OF HELSINKI   (Finland)

^e SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^f DANUBE UNIVERSITY KREMS   (Austria)

^g ST MARY S HOSPITAL   (United Kingdom)

Author keywords

cancer mortality; diabetes; glucose tolerance

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AFRICAN; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER MORTALITY; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ESOPHAGUS CANCER; ETHNIC GROUP; FEMALE; GALLBLADDER CANCER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INDIAN; INSULIN BLOOD LEVEL; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MALE; MAURITIUS; NASOPHARYNX CANCER; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY CANCER; PENIS CANCER; PHARYNX CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SKIN CANCER; SMOKING; SYSTOLIC BLOOD PRESSURE; TESTIS CANCER; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; MAURITIUS; MIDDLE AGED; NEOPLASMS; RISK FACTORS; YOUNG ADULT;

EID: 84867063472     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27503     Document Type: Article

References (32)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang Y, Stevens GA, Rao M, Ali MK, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011; 378: 31-40.
2. Shaw JE, Sicree RA, Zimmet PZ,. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
3. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM,. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202.
4. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S,. Diabetes mellitus and risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871-7.
5. Lam EKK, Batty GD, Huxley RR, Martiniuk ALC, Barzi F, Lam TH, Lawes CMM, Giles GG, Welborn T, Ueshima H, Tamakoshi A, Woo J, et al. Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann Oncol 2010; 22: 730-8.
6. Wild S,. Diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations. Diabetologia 2011; 54: 1589-92.
7. Larsson SC, Orsini N, Wolk A,. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-87.
8. La Vecchia C, Negri E, Decarli A, Franceschi S,. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997; 73: 204-7.
9. Huxley R, Ansary-Moghaddam A, de Gonzalez A, Barzi F, Woodward M,. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076-83.
10. Washio M, Mori M, Khan M, Sakauchi F, Watanabe Y, Ozasa K, Hayashi K, Mik iT, Nakao M, Mikami K, Ito Y, Kubo T, et al. Diabetes mellitus and kidney cancer risk: the results of Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study). Int J Urol 2007; 14: 393-7.
11. Weiderpass E, Gridley G, Persson I, Nyren O, Ekborn A, Adami HO,. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 1997; 71: 360-3.
12. Bo S, Ciccone G, Rosato R, Villois P, Appendino G, Ghigo E, Grassi G,. Cancer mortality reduction and metformin. A retrospective cohort study in type 2 diabetic patients. Diabetes Obes Metab 2012; 14: 23-29.
13. Calle E, Rodriguez C, Walker-Thurmond K, Thun M,. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-238.
14. Soderberg S, Zimmet P, Tuomilehto J, De Courten M, Dowse GK, Chitson P, Stenlund H, Gareeboo H, Alberti KGMM, Shaw J,. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose intolerance to diabetes in Mauritius. J Intern Med 2004; 256: 37-47.
15. Soderberg S, Zimmet P, Tuomilehto J, De Courten M, Dowse GK, Chitson P, Gareeboo H, Alberti KGMM, Shaw J,. Increasing prevalance of Type 2 diabetes mellitus in all ethnic groups in Mauritius. Diabet Med 2005; 22: 61-8.
16. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, Horlick M, Kotler D, Laferrere B, Mayer L, Pi-Sunyer FX, Pierson RNJ,. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr 2003; 77: 379-84.
17. Magliano DJ, Soderberg S, Zimmet PZ, Cartensen B, Balkau B, Pauvaday V, Kowlessur S, Tuomilehto J, Alberti KGMM, Shaw JE,. Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic Mauritius: impact of diabetes and intermediate forms of glucose tolerance. Diabetes Care 2010; 33: 1983-9.
18. World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: Diangosis and Classification of Diabetes Mellitues. Geneva: Department of Noncommunicable Disease Surveillance, 1999.
19. Tuomilehto J, Dabee J, Karvonen M, Dowse GK, Gareeboo H, Virtala E, Tiihonen M, Alberti KG, Zimmet PZ,. Incidence of IDDM in Mauritian children and adolescents from 1986 to 1990. Diabetes Care 1993; 16: 1588-91.
20. Soeldner J, Slone D,. Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes Care 1965; 14: 771-9.
21. Wallace TM, Levy JC, Matthews DR,. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-95.
22. Thiebaut AC, Benichou J,. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 2004; 23: 3803-20.
23. Ferrannini E, Massari M, Nannipieri M, Natali A, Ridaura RL, Gonzales-Villalpando C,. Plasma glucose levels as predictors of diabetes: the Mexico Coty diabetes study. Diabetologia 2009; 52: 818-24.
24. Saydah SH, Loria CM, Eberhardt MS, Brancati FL,. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003; 157: 1092-100.
25. Batty GD, Shipley MJ, Marmot M, Smith GD,. Diabetes status and post-load plasma glucose concentration in relation to site-specific mortality: findings from the original Whitehall study. Cancer Causes Control 2004; 15: 873-81.
26. Abe R, Yamagishi S,. AGE-RAGE system and carcinogenesis. Curr Pharm Des 2008; 14: 940-5.
27. Pollak M,. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008; 8: 915-28.
28. Richardson LC, Pollack LA,. Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2005; 2: 48-53.
29. van de Poll-Franse LV, Houterman S, Janssen-Heijnen MLG, Dercksen MW, Coebergh JWW, Haak HR,. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 2007; 120: 1986-92.
30. Del Boca FK, Darkes J,. The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction 2003; 98 (Suppl 2): 1-12.
31. Chan D,. So why ask me? Are self report data really that bad? In:, Lance CE, Vandenberg RJ, eds. Statistical and methodological myths and urban legends: Doctrine, verity and fable in the organizational and social sciences. New York, NY: Routledge, 2009. 309-35.
32. Johnson JA, Bowker SL, Richardson K, Marra CA,. Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia 2011; 54: 2263-71.